NTRK2 and central nervous system cancer: Using immuno-electron microscopy with immunogold labelling of GFP+ cells to unambiguously identify the malignant cells, we identified fewer neuron-to-glioma synaptic structures in the NTRK2-KO tumours compared with wild-type tumours (Fig. 4c,d and Extended Data Fig. 10a).